Reducing Decannulation Time: Limitation of Decannulation Capping Trials (REDECAP) (REDECAP)

August 6, 2018 updated by: Gonzalo Hernandez Martinez, Hospital Virgen de la Salud

Reducing Decannulation Time in Critically-ill Tracheostomized Patients: Decannulation Capping Trial Protocol vs Frequency Aspiration Protocol (REDECAP)

Multicenter randomized trial centered on critically-ill tracheostomized patients, comparing two different decannulation protocols:

  1. based on capping trials to decide decannulation,
  2. based on the aspiration frequency to decide decannulation time. High-flow conditioned oxygen therapy will be applied to all patients through the tracheal cannula. In patients included in the suctioning frequency based protocol along the study period and in patients included in the capping trial protocol along periods out of capping trials.

Study Overview

Study Type

Interventional

Enrollment (Actual)

330

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain
        • Hospital del Mar
      • Barcelona, Spain
        • Hospital Universitario Vall D´Ebron
      • Ciudad Real, Spain
        • Hospital Universitario de Ciudad Real
      • Madrid, Spain
        • Hospital Universitario Ramon y Cajal
      • Toledo, Spain
        • Hospital Virgen de la Salud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Critically-ill tracheostomized patients weaned from mechanical ventilation (24 consecutive hours disconnected).

Exclusion Criteria:

  • Patients consedered non-decannulable at time of randomization:

    1. unconscious patient (motor component of GCS score <6 points).
    2. Severe swallowing function (based on drink test).
    3. Airway patency problem (based of intolerance of occlusion test).
    4. Neuromuscular diseases.
    5. Patients with a Sabadell score >2.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Capping trial protocol

Decannulation protocol based on tolerance to 24 hours capping trial to decide when to decannulate.

Decapping during the capping trial for aspiration of respiratory secretions is considered a failure criteria of the trial.

High flow conditioned oxygen therapy through tracheal cannula will be applied during periods out of capping trials.

Experimental: Suctioning frequency protocol

Decannulation protocol based on suctioning frequency to decide when to decannulate (criteria: ≤2 aspirations every 8 h along 24 consecutive hours).

Intervention: suctioning frequency of respiratory secretions will be recorded untill fulfill decannulation criteria. Capping trials will not be allowed in this group.

High flow conditioned oxygen therapy will be applied through tracheal cannula during all the study period.

Comparison of two different decannulation protocols: one protocol based on capping trial tolerance to decide when to decannulate vs. protocol based on suctioning frequency of respiratory secretions to decide when to decannulate (criteria: ≤2 aspirations every 8 h along 24 consecutive hours).
High flow conditioned oxygen therapy will be applied during all study period through tracheal cannula in the experimental arm (suctioning frequency based protocol) and during periods out of capping trials in the control arm (capping trials based protocol).
Other Names:
  • OptiflowTM, Fisher&Paykel, Auckland, New Zealand.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decannulation time
Time Frame: Patients will be followed for the duration of hospital stay, an expected average of 3 months
Time since weaning from mechanical ventilation (24 consecutive hours disconnected) to decannulation
Patients will be followed for the duration of hospital stay, an expected average of 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decannulation failure
Time Frame: Patients will be followed for the duration of hospital stay, an expected average of 3 months
Number of patients requiring recannulation during hospital stay / number of patients included in the group X 100
Patients will be followed for the duration of hospital stay, an expected average of 3 months
Intensive Care Unit Lenght of stay
Time Frame: Patients will be followed for the duration of ICU stay, an expected average of 2 months
Time since ICU admission to ICU discharge
Patients will be followed for the duration of ICU stay, an expected average of 2 months
Hospital lenght of stay
Time Frame: Patients will be followed for the duration of hospital stay, an expected average of 3 months
Time since hospital admission to hospital discharge
Patients will be followed for the duration of hospital stay, an expected average of 3 months
ICU mortality
Time Frame: Patients will be followed for the duration of ICU stay, an expected average of 2 months
ICU mortality in every study group
Patients will be followed for the duration of ICU stay, an expected average of 2 months
Hospital mortality
Time Frame: Patients will be followed for the duration of hospital stay, an expected average of 3 months
Hospital mortality in every study group
Patients will be followed for the duration of hospital stay, an expected average of 3 months
Respiratory infection
Time Frame: Patients will be followed for the duration of hospital stay, an expected average of 3 months
Post-randomization pneumonia and tracheobronchitis rate in every study group
Patients will be followed for the duration of hospital stay, an expected average of 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Gonzalo Hernandez, MD, Hospital Virgen de la Salud

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2016

Primary Completion (Actual)

May 1, 2018

Study Completion (Actual)

May 1, 2018

Study Registration Dates

First Submitted

July 27, 2015

First Submitted That Met QC Criteria

July 28, 2015

First Posted (Estimate)

July 31, 2015

Study Record Updates

Last Update Posted (Actual)

August 7, 2018

Last Update Submitted That Met QC Criteria

August 6, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 3/7/2015 n67

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tracheostomy

Clinical Trials on Decannulation protocol.

Subscribe